| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |